Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001274173-25-000205·JANUS HENDERSON GROUP PLC
Schedule 13G ownership disclosure
Tenax Therapeutics, Inc.
Common Stock · CUSIP: 88032L605
Event date: 2025-06-30
- Filing-level shares
- 166,666
- Percent of class
- 4.0%
- JANUS HENDERSON GROUP PLC
Shares: 166,666 · Class: 4.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-25-000205
- Form type
- SCHEDULE 13G/A
- Filer
- JANUS HENDERSON GROUP PLC
- CIK
- CIK 1274173
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership